🔴 Optimi Health is trading 7.33% down in after-hours trading amid hotter-than-expected producer inflation and rate concerns

Optimi Health is trading at $4.17 (-7.33%) in after-hours trading as broader risk-off sentiment follows hotter-than-expected producer inflation and rate concerns.

• The S&P 500 fell 0.52%, while geopolitical tensions and oil above $100 pressured markets.
• On September 10, Optimi Health announced a Health Canada-authorized Phase 2 depression trial, but the bullish news does not explain the opposite-direction after-hours decline.
• The trial plans to enroll up to 200 participants, with dosing expected to finish by the end of 2027.